Prosecution Insights
Last updated: November 20, 2026
Application No. 18/293,383

COMPOSITION AND METHOD FOR SYNTHESIS OF AN ALKOXY-FUNCTIONAL ORGANOSILOXANE OLIGOMER

Non-Final OA §103§112
Filed
Jan 30, 2024
Priority
Oct 21, 2021 — provisional 63/270,073 +2 more
Examiner
XU, JIANGTIAN
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Dow Global Technologies LLC
OA Round
1 (Non-Final)
65%
Grant Probability
Moderate
1-2
OA Rounds
6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 65% of resolved cases
65%
Career Allowance Rate
235 granted / 363 resolved
At TC average
Strong +36% interview lift
Without
With
+36.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
73 currently pending
Career history
429
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
56.8%
+16.8% vs TC avg
§102
14.3%
-25.7% vs TC avg
§112
24.0%
-16.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 363 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I (claims 1-3) in the reply filed on 9/14/2026 is acknowledged. The traversal is on the ground(s) that the combination of Wengrovious and Gohndrone cannot produce the alkoxy-functional organosiloxane oligomer of claim 1. When Gohndrone's oligomer of formula (V) is used in Wengrovious's method, condensation reactions with the alkoxy terminal groups would occur. The silicon-bonded hydrogen atom would remain unreacted while the alkoxy terminal groups would be consumed. This is not found persuasive because Gohndrone's oligomer of formula (V) is identical to the (A) an alkoxy-functional organohydrogensiloxane oligomer in claim 4. Wengrovious's acetylacetone is identical to the (B) in claim 4. Applicant’s Example 3 [0042 pgpub] discloses ETM reacting with acetylacetone with catalyst at 100 °C. Wengrovious teaches similar method in Example 10: reacting polyalkoxy-terminated polydiorganosiloxane with acetylacetone with the tin catalyst (dibutyltin bis(acetylacetonate) which is identical to the claimed (B)) at 100 °C [P8L50-58]. Applicant did not explain why the oligomer in claim 1 can be obtained when the (A) is used to react with the (B) in claim 4, but can’t be obtained when Gohndrone's oligomer of formula (V) is used to react with acetylacetone. The requirement is still deemed proper and is therefore made FINAL. Groups II and III (claims 4-15) are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 9/14/2026. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-3 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites a formula containing R3. However, the claim does not define the recited R3. This renders the claim indefinite. For the purpose of further examination, the R3 is interpreted as a monovalent hydrocarbon group, as disclosed in the specification [0007 spec.]. Claims 2-3 are rejected likewise as depending on claim 1. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-3 are rejected under 35 U.S.C. 103 as being unpatentable over Wengrovious et al (EP 0304701 A2) in view of Gohndrone et al (US 20200140618 A1). Regarding claims 1-3, the recited oligomer is made from reaction starting materials of (A) and (B) in claim 4. Applicant’s Example 3 discloses reacting ETM (the recited (A)) with acetylacetone (the recited (B)) in the presence of a catalyst at 100 °C [0042 pgpub]. Wengrovious teaches a room temperature vulcanizable polydiorganosiloxane prepared from a composition comprising: (A) at least one polyalkoxy-terminated polydior-ganosiloxane and (B) a catalytic amount of an organotin complex including acetylacetone [P7L2-7 and P7L43] which reads on the claimed (B) in claim 4, as evidenced by the applicant [0013 pgpub]. Wengrovious teaches a method of making a room temperature vulcanizable composition in Example 10: reacting a polyalkoxy-terminated polydiorganosiloxane with acetylacetone in the presence of a tin catalyst (dibutyltin bis(acetylaceton­ate) which is identical to the claimed (B)) at 100 C [P8L50-58]. This process is substantially identical to the process disclosed in applicant’s Example 3. Wengrovious’ (A) polyalkoxy-terminated polydior-ganosiloxane is not the same as the recited (A) in claim 4. Gohndrone teaches an alkoxy-functional organohydrogensiloxane oligomer of formula (V) [0021]: PNG media_image1.png 200 400 media_image1.png Greyscale which is identical to the recited (A) in claim 4. Wengrovious and Gohndrone are in the same field of endeavor, for both are interested in making a room temperature vulcanizable sealant product (Gohndrone [0054], Wengrovious [P7L4-5]). It is prima facie obvious to substitute equivalents for the same purpose where the equivalence is recognized by the prior art. See MPEP 2144.06. Since Gohndrone’s oligomer of formula (V) and Wengrovious’ polyalkoxy-terminated polydior-ganosiloxane are equivalent for the same purpose of making a room temperature vulcanizable sealant, it would have been obvious for one of ordinary skilled in the art at the time of filing to substitute Wengrovious’ polyalkoxy-terminated polydior-ganosiloxane with Gohndrone’s oligomer of formula (V) in Wengrovious’ method. As disclosed by the applicant (claim 4 and Example 3), the product of reacting Gohndrone’s oligomer of formula (V) with Wengrovious’ acetylacetone is the alkoxy-functional organosiloxane oligomer of formula PNG media_image2.png 200 400 media_image2.png Greyscale in claim 1. Gohndrone’s R1 includes methyl, R3 is independently a monovalent hydrocarbon group of 1 to 18 carbon atoms, subscript a is 0 or 1, subscript c can be 0, D is independently a divalent hydrocarbon group of 2 to 18 carbon atoms [0016, 0019-0021] coming from R2 of formula (II) PNG media_image3.png 200 400 media_image3.png Greyscale wherein R2 can be a vinyl group [0026]. Therefore, D can be (C2H4)-. Wengrovious’ acetylacetone reads on the recited (B) of formula R10-O-H in claim 4 and will be converted to the claimed R10-O group when being reacted with Gohndrone’s alkoxy-functional organohydrogensiloxane oligomer of formula (V), wherein R8 and R9 are each methyl in R10. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JIANGTIAN XU whose telephone number is (571)270-1621. The examiner can normally be reached Monday-Thursday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached on (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JIANGTIAN XU/Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Jan 30, 2024
Application Filed
Oct 29, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12799277
APROTIC CATALYSTS FOR THE HYDROLYSIS / CONDENSATION OF ORGANOALKOXYSILANES
3y 11m to grant Granted Nov 17, 2026
Patent 12780993
CROSSLINKED ORGANIC SILICON RESIN, A METHOD FOR PREPARING THE SAME, AND A COSMETIC
2y 10m to grant Granted Nov 03, 2026
Patent 12767735
METHOD OF MANUFACTURING POLYMERIZABLE COMPOSITION, POLYMERIZABLE COMPOSITION, AND CURED PRODUCT
3y 5m to grant Granted Oct 20, 2026
Patent 12758899
POLYETHYLENIMINE AS A NEW EMULSION BREAKER FOR QUENCH WATER SYSTEMS
1y 8m to grant Granted Oct 13, 2026
Patent 12752249
Preparation Method Of High-Efficiency Gel For Seawater Desalination
3y 1m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+36.1%)
3y 3m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 363 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month